Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis

WJ Yang, J Hu, A Uemura, F Tetzlaff… - EMBO molecular …, 2015 - embopress.org
WJ Yang, J Hu, A Uemura, F Tetzlaff, HG Augustin, A Fischer
EMBO molecular medicine, 2015embopress.org
Retinopathy of prematurity causes visual impairment due to destructive neoangiogenesis
after degeneration of the retinal microvasculature. This study was aimed at analyzing
whether local delivery of Semaphorin‐3C (Sema3C) suppresses pathological retinal
angiogenesis. Sema3C exerted potent inhibiting effects in cellular models of angiogenesis.
In an endothelial cell xenotransplantation assay, Sema3C acted primarily on immature
microvessels by inducing endothelial cell apoptosis. Intravitreal administration of …
Abstract
Retinopathy of prematurity causes visual impairment due to destructive neoangiogenesis after degeneration of the retinal microvasculature. This study was aimed at analyzing whether local delivery of Semaphorin‐3C (Sema3C) suppresses pathological retinal angiogenesis. Sema3C exerted potent inhibiting effects in cellular models of angiogenesis. In an endothelial cell xenotransplantation assay, Sema3C acted primarily on immature microvessels by inducing endothelial cell apoptosis. Intravitreal administration of recombinant Sema3C disrupted endothelial tip cell formation and cell–cell contacts, which led to decreased vascular bed expansion and vessel branching in the growing retinal vasculature of newborn mice, while not affecting mature vessels in the adult retina. Sema3C administration strongly inhibited the formation of pathological pre‐retinal vascular tufts during oxygen‐induced retinopathy. Mechanistically, Sema3C signaled through the receptors Neuropilin‐1 and PlexinD1, which were strongly expressed on vascular tufts, induced VE‐cadherin internalization, and abrogated vascular endothelial growth factor (VEGF)‐induced activation of the kinases AKT, FAK, and p38MAPK. This disrupted endothelial cell junctions, focal adhesions, and cytoskeleton assembly resulted in decreased cell migration and survival. Thus, this study identified Sema3C as a potent and selective inhibitor of pathological retinal angiogenesis.
embopress.org